van Rooij L, van den Broek M, Rademaker C, de Vries L
Paediatr Drugs. 2013; 15(1):9-18.
PMID: 23334995
DOI: 10.1007/s40272-012-0005-1.
Beleboni R, Carolino R, Pizzo A, Castellan-Baldan L, Coutinho-Netto J, dos Santos W
Cell Mol Neurobiol. 2005; 24(6):707-28.
PMID: 15672674
PMC: 11529967.
DOI: 10.1007/s10571-004-6913-z.
Loscher W, Horstermann D
Naunyn Schmiedebergs Arch Pharmacol. 1994; 349(3):270-8.
PMID: 8208305
DOI: 10.1007/BF00169293.
Knepel W, Nutto D, Hertting G
Pflugers Arch. 1980; 388(2):177-83.
PMID: 7192856
DOI: 10.1007/BF00584125.
Szerb J
Neurochem Res. 1982; 7(2):191-204.
PMID: 7121708
DOI: 10.1007/BF00965057.
A comparative study of the pharmacology of inhibitors of GABA-metabolism.
Loscher W
Naunyn Schmiedebergs Arch Pharmacol. 1980; 315(2):119-28.
PMID: 6782493
DOI: 10.1007/BF00499254.
Aminooxyacetic acid induced accumulation of GABA in the rat brain. Interaction with GABA receptors and distribution in compartments.
Pagliusi S, Gomes C, Leite J, Trolin G
Naunyn Schmiedebergs Arch Pharmacol. 1983; 322(3):210-5.
PMID: 6306485
DOI: 10.1007/BF00500767.
Cellular compartments of GABA in brain and their relationship to anticonvulsant activity.
Iadarola M, Gale K
Mol Cell Biochem. 1981; 39:305-29.
PMID: 6273710
DOI: 10.1007/BF00232582.
The GABA postsynaptic membrane receptor-ionophore complex. Site of action of convulsant and anticonvulsant drugs.
Olsen R
Mol Cell Biochem. 1981; 39:261-79.
PMID: 6273709
DOI: 10.1007/BF00232579.
GABA agonists. Development and interactions with the GABA receptor complex.
Krogsgaard-Larsen P, Falch E
Mol Cell Biochem. 1981; 38 Spec No(Pt 1):129-46.
PMID: 6270544
DOI: 10.1007/BF00235692.
Inhibitors of the GABA uptake systems.
Krogsgaard-Larsen P
Mol Cell Biochem. 1980; 31(2):105-21.
PMID: 6251361
DOI: 10.1007/BF00240816.
Electroencephalographic and behavioural effects of sodium valproate in patients with photosensitive epilepsy. A single dose trial.
Myslobodsky M, Mintz M, Douglas R
J Neurol. 1980; 224(2):111-23.
PMID: 6160215
DOI: 10.1007/BF00313349.
Glutamate, GABA, and CNS disease: a review.
Walker J
Neurochem Res. 1983; 8(4):521-50.
PMID: 6136926
DOI: 10.1007/BF00965107.
Effects of anticonvulsants in vivo on high affinity choline uptake in vitro in mouse hippocampal synaptosomes.
Miller J, Richter J
Br J Pharmacol. 1985; 84(1):19-25.
PMID: 3978310
PMC: 1987204.
Effects of the gamma-aminobutyrate transaminase inhibitors gabaculine and gamma-vinyl GABA on gamma-aminobutyric acid release from slices of rat cerebral cortex.
Bedwani J, Mehta A
Neurochem Res. 1987; 12(1):49-52.
PMID: 3574587
DOI: 10.1007/BF00971363.
5-Fluoromethylornithine, an irreversible and specific inhibitor of L-ornithine:2-oxo-acid aminotransferase.
Daune G, Gerhart F, Seiler N
Biochem J. 1988; 253(2):481-8.
PMID: 3178724
PMC: 1149323.
DOI: 10.1042/bj2530481.
Evidence for the presence of a benzodiazepine receptor binding substance in cerebrospinal fluid of a rabbit model of hepatic encephalopathy.
Mullen K, Martin J, Mendelson W, Jones E
Metab Brain Dis. 1989; 4(4):253-60.
PMID: 2557531
DOI: 10.1007/BF00999771.
Pharmacokinetics of the individual enantiomers of vigabatrin (gamma-vinyl GABA) in epileptic children.
Rey E, Pons G, Richard M, Vauzelle F, dAthis P, Chiron C
Br J Clin Pharmacol. 1990; 30(2):253-7.
PMID: 2206786
PMC: 1368225.
DOI: 10.1111/j.1365-2125.1990.tb03772.x.
GABA-transaminase activity in rat and human brain: regional, age and sex-related differences.
Sherif F, Eriksson L, Oreland L
J Neural Transm Gen Sect. 1991; 84(1-2):95-102.
PMID: 2054153
DOI: 10.1007/BF01249113.
Gamma-aminobutyrate aminotransferase activity in brains of schizophrenic patients.
Sherif F, Eriksson L, Oreland L
J Neural Transm Gen Sect. 1992; 90(3):231-40.
PMID: 1285951
DOI: 10.1007/BF01250964.
